The global bioprocess automation market was valued at USD 8.6 billion in 2025. According to Grand View Research, the market is expected to reach USD 9.5 billion in 2026 and expand to USD 22.2 billion by 2033, representing a 12.8% CAGR from 2026 to 2033.

North America remained the leading regional market, accounting for 42.7% of global revenue in 2025. Strong demand for biologics, increasing adoption of artificial intelligence (AI) and robotics, and stringent requirements for manufacturing consistency and regulatory compliance are supporting market expansion. Meanwhile, Asia Pacific is projected to record the fastest CAGR during 2026–2033.

Market at a Glance

Source: Grand View Research, IR Documents, Primary Interviews, and Paid Databases.

What Is Driving Bioprocess Automation Adoption?

The accelerating production of biologics is one of the primary factors increasing demand for automated bioprocessing technologies. Pharmaceutical and biotechnology companies are expanding the development and manufacturing of monoclonal antibodies, vaccines, gene therapies, and other advanced biologic products used to address complex diseases, including cancer, autoimmune disorders, and rare genetic conditions.

Biologic manufacturing requires tightly controlled and repeatable production environments. As manufacturing volumes increase, conventional manual and semi-automated workflows can create challenges related to labor requirements, process variability, operational errors, scalability, and quality control.

Bioprocess automation addresses these challenges by enabling continuous monitoring, automated process control, data collection, and standardized production workflows. These capabilities help manufacturers improve process consistency while supporting higher production efficiency and compliance with increasingly demanding quality standards.

Download a free sample report or claim your copy of this full market intelligence report

Technology Innovation Is Reshaping the Industry

Technological advancement is another defining characteristic of the bioprocess automation market. Automation platforms are increasingly incorporating AI, machine learning, robotics, and Internet of Things (IoT) technologies to improve process visibility and decision-making.

These technologies enable manufacturers to monitor complex bioprocess parameters, identify deviations, optimize operating conditions, and apply predictive analytics. Adaptive process control can also reduce variability and improve the consistency and quality of biopharmaceutical production.

The competitive landscape is therefore moving beyond conventional automation toward integrated digital ecosystems capable of connecting equipment, process data, analytics, and control systems across the manufacturing workflow.

Looking for more in-depth data focusing on specific segments or regions? Get this report customized with inclusion of custom data sets to suit your exact business needs.

Market Structure and Competitive Developments

The market is characterized by continued innovation and strategic collaboration among established automation providers, life sciences companies, and technology-focused businesses. Mergers, acquisitions, and partnerships are increasingly being used to strengthen capabilities in AI, robotics, digitalization, analytics, and automated process monitoring.

For example, in September 2025, Yokogawa Corporation and Repligen announced a partnership integrating OpreX Bio Pilot with MAVERICK to improve automated glucose and lactate monitoring in bioprocessing applications. Such collaborations reflect the industry's broader movement toward connected, integrated, and end-to-end automation solutions.

Segment and Regional Leaders

• Product & services: Process automation hardware represented the largest segment, with a 31.4% market share in 2025.
• Process stage: The upstream segment held the leading position in 2025.
• End use: Pharmaceutical & biotechnology manufacturers accounted for the largest share in 2025.
• Leading region: North America, with 42.7% of global revenue in 2025.
• Fastest-growing region: Asia Pacific, based on the highest projected CAGR from 2026 to 2033.
• Leading country market: The U.S. represented the largest revenue share within the bioprocess automation industry in 2025.

Competitive Landscape

Key companies profiled in the bioprocess automation market include:

• Thermo Fisher Scientific Inc.
• Sartorius AG
• Parker Hannifin Corp.
• Danaher
• Merck KGaA
• Eppendorf SE

These companies compete through automation hardware, process-control technologies, digital solutions, monitoring capabilities, and integrated bioprocessing platforms. Continued investment in automation, data-driven manufacturing, and intelligent process control is expected to remain central to competitive positioning as biopharmaceutical production becomes increasingly sophisticated.

Explore the full list of profiled companies operating in this market with recent strategic initiatives

Explore our dedicated business services:

• Brainshare Consulting – End-to-end business consulting services including Opportunity assessment, GTM support, Competitive intelligence, and Consumer Analytics.
• Custom Research – Get a market intelligence report tailored to your specific requirements and aligned with your business goals.
• Consumer Insights – Capture real, evolving consumer sentiment and behavior to help you make data driven strategies.
• Horizon Databooks – Access the world’s largest portal of Market Reports & Statistics
• Investment Insights – Make investment decisions with data driven insights, powered by domain and technology
• Signal (Pricing Intelligence) - Commodity price intelligence to drives strategic advantage.

About us:
Grand View Research, a market research and consulting company, provides syndicated research reports, customized research reports, and consulting services. Grand View Research database is used by the world's renowned academic institutions and Fortune 500 companies to understand the global and regional business environment. Our database features thousands of statistics and in-depth analysis on 46 industries in 25 major countries worldwide.